UNIVERSITY OF CALIFORNIA, IRVINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1965-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uci.edu
My Life and My Experiences Project
Not Applicable
Recruiting
- Conditions
- Stress and Memory in Adolescence
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 400
- Registration Number
- NCT06821178
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
Management of Acute Tinnitus With Migraine Medications
Phase 4
Recruiting
- Conditions
- Tinnitus
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 100
- Registration Number
- NCT06799169
- Locations
- 🇺🇸
University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange, California, United States
Physical Activity in Acute Lymphoblastic Leukemia (ALL)
Not Applicable
Completed
- Conditions
- Acute Leukemia
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 21
- Registration Number
- NCT06783738
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
Phase 2
Recruiting
- Conditions
- MelanomaMelanoma Stage IIIMelanoma (Skin)Melanoma Stage IV
- Interventions
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 14
- Registration Number
- NCT06771544
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center University of California, Irvine, Orange, California, United States
EndoPAT Device for Endothelial Dysfunction in ED
Not Applicable
Not yet recruiting
- Conditions
- Erectile DysfunctionHypogonadism, MaleEndothelial Dysfunction
- Interventions
- Drug: Daily low-dose PDE5 inhibitor therapy
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 120
- Registration Number
- NCT06720597
- Locations
- 🇺🇸
UCI Urology | Men's Health Center, Newport Beach, California, United States
Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
Phase 2
Recruiting
- Conditions
- HNSCCHead and Neck Squamous Cell Carcinoma
- Interventions
- Drug: AHCC®capsules
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 34
- Registration Number
- NCT06693323
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
Vaginal Changes After CO2 Laser
Not Applicable
Recruiting
- Conditions
- Genitourinary Syndrome of Menopause
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 50
- Registration Number
- NCT06691178
- Locations
- 🇺🇸
Beckman Laser Institute, Irvine, California, United States
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence
Phase 2
Recruiting
- Conditions
- Urothelial CarcinomaMuscle-invasive Bladder Cancer
- Interventions
- Drug: Sacituzumab Govitecan (SG)
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 23
- Registration Number
- NCT06682728
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer
Not Applicable
Active, not recruiting
- Conditions
- Quality of LifePediatric CancerCaregiver Burden
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 33
- Registration Number
- NCT06622252
- Locations
- 🇺🇸
CHOC Children's, Orange, California, United States
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2
Recruiting
- Conditions
- Breast CancerSarcomaGastric CancerLung CancerHead and Neck CancerColorectal CancerOvarian CancerLiver CancerGenitourinary CancerGynecologic Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 51
- Registration Number
- NCT06580002
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, United States